Dolphin Medical Services (BOM:526504) Long-Term Debt: ₹8.66 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:526504 Dolphin Medical Services Ltd BOM:526504
36 GF Score
Price ₹7.87
GF Value ₹2.39
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Dolphin Medical Services Long-Term Debt?

Dolphin Medical Services BOM:526504 36 Long-Term Debt is ₹8.66 Mil as of Mar. 2026. GuruFocus rates BOM:526504 with a GF Score™ of 36/100 and a GF Value™ of ₹2.39 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Dolphin Medical Services's Long-Term Debt for the quarter that ended in Mar. 2026 was ₹8.66 Mil.

Dolphin Medical Services's quarterly Long-Term Debt declined from Sep. 2025 (₹8.25 Mil) to Dec. 2025 (₹0.00 Mil) but then increased from Dec. 2025 (₹0.00 Mil) to Mar. 2026 (₹8.66 Mil).

Dolphin Medical Services's annual Long-Term Debt increased from Mar. 2024 (₹8.03 Mil) to Mar. 2025 (₹8.66 Mil) but then stayed the same from Mar. 2025 (₹8.66 Mil) to Mar. 2026 (₹8.66 Mil).

Dolphin Medical Services  (BOM:526504) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Dolphin Medical Services Long-Term Debt Related Terms

Dolphin Medical Services Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Dolphin Medical Services's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dolphin Medical Services Long-Term Debt Chart

Dolphin Medical Services Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.84 7.55 8.03 8.66 8.66

Dolphin Medical Services Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.66 0.00 8.25 0.00 8.66
BOM:526504
36GF Score
Dolphin Medical Services Ltd BOM:526504
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of ₹8.66 Mil mean?
Dolphin Medical Services (BOM:526504) has a Long-Term Debt of ₹8.66 Mil as of Mar. 2026.
Is Dolphin Medical Services' Long-Term Debt too high?
Dolphin Medical Services' current Long-Term Debt is ₹8.66 Mil. Overall, Dolphin Medical Services has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dolphin Medical Services' Long-Term Debt compare to TMO and DHR?
Dolphin Medical Services' Long-Term Debt of ₹8.66 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Diagnostics & Research company?
A good Long-Term Debt depends on the Medical Diagnostics & Research industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Dolphin Medical Services's current Long-Term Debt is ₹8.66 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dolphin Medical Services stock overvalued right now?
Based on GuruFocus' analysis, Dolphin Medical Services (BOM:526504) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹2.39, compared to a current price of ₹7.87 — trading 229.3% above its estimated fair value. The current Long-Term Debt is ₹8.66 Mil. Dolphin Medical Services' overall GF Score™ is 36/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Dolphin Medical Services (BOM:526504), the current Long-Term Debt is ₹8.66 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dolphin Medical Services (BOM:526504) Overvalued in 2026?

Based on GuruFocus' analysis, Dolphin Medical Services stock appears to be overvalued. The current stock price of ₹7.87 is trading 229.3% above its estimated GF Value™ of ₹2.39. GuruFocus considers Dolphin Medical Services to be Significantly Overvalued.

Key valuation signals for BOM:526504:

  • Long-Term Debt: ₹8.66 Mil
  • GF Value™: ₹2.39 vs. price of ₹7.87 (229.3% above fair value)
  • GF Score™: 36/100 with 3 warning signs

No single metric tells the full story. See the BOM:526504 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dolphin Medical Services Business Description

Address Kovelamudivari Veedhi, D.No.29-28/1-27, Suryaraopet, Vijayawada, AP, IND, 520002
Dolphin Medical Services Ltd is engaged in providing diagnostics and other allied services. It includes a range of tests covering radiology and imaging, biochemistry, pathology, and microbiology. In addition, the company is also involved in Information Technology, Biotechnology, and Herbal sectors. Services provided by the company are Diagnostic Centre provides all the services under one roof; the Ophthalmic Laser Care Centre provides total laser eye treatment as "Dolphin Nethralaya"; Teleradiology Services; Clinical Trials and Life Sciences division; Medical Equipment & Goods associated distribution; Bio-Tech Division is to provide Foods and Herbal Products and Dolphin Electronic Solution and Technologies(DEST).
36GF Score

Get the complete analysis for BOM:526504

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹7.87
Price
₹2.39
GF Value